Sino-American Tianjin SmithKline Pharmaceutical Co., Ltd., Xincontec, one of the top ten brands of cold medicine, entered the joint venture brand of cold medicine in China earlier, has a series of products of aminamamine tablets and ventilation nasal patches, and focuses on the research, production and sales of cold medicine products
Leading China's cold medicine market with a high market share, with an annual growth rate higher than the growth level of the entire category.
Over the past 20 years, the brand growth process has been condensed into a strong brand power, so that the new Contec is used and trusted by more and more consumers.
Contec Memorabilia:
In 1961, "Contec" was launched in the United States, and the advanced "time-controlled pellet, sustained-release technology" became the unique selling point of the product.
In 1966, "Contec 600" was officially launched in Japan as a promotional core that was effective for 12 hours after taking one pill.
In 1988, Contec entered China and became the first joint venture brand of cold medicine in China.
1993 Contec launched its first television commercial.
In 2001, after technical improvements, the new Contec without PPA was born.
In 2004, the new Contec launched a new product for the first time, targeting colds and fevers - the new Contec Qing.
In 2007, in order to establish a unified brand platform, the brand character - Mr. Xin Kangtai was transformed to carry and convey the brand promise. Under the same brand of New Contec, a new product was launched - New Contec Red Suit was launched.
Sino-US Tianjin SmithKline Pharmaceutical Co., Ltd.:
Sino-US Tianjin SmithKline Pharmaceutical Co., Ltd. is a consumer health care products company jointly invested by GlaxoSmithKline (GSK), one of the world's largest pharmaceutical companies, and Tianjin Zhongxin Pharmaceutical Co., Ltd. and Tianjin Taiping (Group) Co., Ltd., large domestic pharmaceutical companies.
As one of the earliest foreign joint venture pharmaceutical companies established in China, Sino-US SmithKline took root in China as early as 1987. Over the past 20 years, Sino-American SmithKline has been adhering to the concept of great love and remembering the heart, and repaying the society with high-quality products and love. In 2008, in addition to the four major OTC brands that consumers are familiar with, Xincontec, Fenbid, Baiduobang and SmithKline, the Sino-American SmithKline family also successfully launched the anti-tooth sensitivity toothpaste recommended by dentists around the world. In 2008, the new Contec and Fenbide brand families added new members, and in 2008, the new Contec red heavy duty was successfully launched; In 2009, the successful launch of the new headache pack of Fenpide phenol coffee tablets will better care for people's healthy life.
SmithKline focuses on people-oriented and has an exciting "3T" corporate culture. The "3T" culture, which began to be implemented in 2007, became more deeply rooted in the hearts of the people in 2008 after a year of infiltration.
The "3T corporate culture" of mutual trust, openness and transparency, and initiative has become the daily work style of SmithKline employees, leading them to grow together with the company.
Sino-American SmithKline has never stopped paying attention to public welfare. In the Wenchuan earthquake, GlaxoSmithKline China donated 10 million yuan to the Chinese Ministry of Health the day after the earthquake, of which 2.6 million yuan was donated by Sino-American SmithKline alone. After that, Sino-American SmithKline also organized employees to go to Dujiangyan, the disaster area, to sponsor the local disaster-stricken schools. In 2008, Sino-American SmithKline used Shi Qinghua, the principal of Guangai School, who took in 103 street children, as the advertising hero of the Fenbide brand, to support Shi Qinghua to better engage in charity education by donating performance fees and donating love and health sports houses, and also carried out the volunteer activity of "Walk with Love, Grow with You" to interact with the street children adopted by Mr. Shi.
